Mirum Pharmaceuticals (NASDAQ:MIRM) Now Covered by Evercore ISI

Share on StockTwits

Evercore ISI initiated coverage on shares of Mirum Pharmaceuticals (NASDAQ:MIRM) in a research report released on Monday morning, BenzingaRatingsTable reports. The firm issued an outperform rating and a $25.00 target price on the stock.

Shares of MIRM stock opened at $13.45 on Monday. Mirum Pharmaceuticals has a one year low of $12.05 and a one year high of $15.50.

In other Mirum Pharmaceuticals news, major shareholder Holdings A/S Novo bought 575,000 shares of the business’s stock in a transaction that occurred on Monday, July 22nd. The shares were purchased at an average cost of $15.00 per share, with a total value of $8,625,000.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Patrick J. Heron bought 450,000 shares of the business’s stock in a transaction that occurred on Monday, July 22nd. The shares were acquired at an average cost of $15.00 per share, for a total transaction of $6,750,000.00. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 1,357,000 shares of company stock worth $20,355,000.

Mirum Pharmaceuticals Company Profile

Mirum Pharmaceuticals, Inc, a clinical-stage therapeutics company, develops and produces therapies for patients with cholestatic liver diseases with a focus on rare pediatric conditions. The company's lead product candidate is maralixibat, a Phase 3-ready investigational oral drug with indications, including Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC).

Recommended Story: What is Blockchain?

Analyst Recommendations for Mirum Pharmaceuticals (NASDAQ:MIRM)

Receive News & Ratings for Mirum Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirum Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Lundin Mining Co.  Insider Nemesia S.a.r.l.  Acquires 150,000 Shares
Lundin Mining Co. Insider Nemesia S.a.r.l. Acquires 150,000 Shares
Brian B. Hansen Sells 15,000 Shares of Tandem Diabetes Care Inc  Stock
Brian B. Hansen Sells 15,000 Shares of Tandem Diabetes Care Inc Stock
Osisko gold royalties Ltd  Director Sells C$897,627.00 in Stock
Osisko gold royalties Ltd Director Sells C$897,627.00 in Stock
Deciphera Pharmaceuticals Inc  Director Sells $917,325.00 in Stock
Deciphera Pharmaceuticals Inc Director Sells $917,325.00 in Stock
Boston Advisors LLC Decreases Stock Holdings in Textron Inc.
Boston Advisors LLC Decreases Stock Holdings in Textron Inc.
Sumedh S. Thakar Sells 6,980 Shares of Qualys Inc  Stock
Sumedh S. Thakar Sells 6,980 Shares of Qualys Inc Stock


© 2006-2019 Ticker Report